Screening for Abdominal Aortic Aneurysm Using a Portable Transthoracic Echocardiography Among Patients With Acute Coronary Syndrome

Screening for Abdominal Aortic Aneurysm Using a Portable Transthoracic Echocardiography (TTE) Among Patients With Acute Coronary Syndrome in Intensive Cardiac Care Unit.

Sponsors

Lead Sponsor: HaEmek Medical Center, Israel

Source HaEmek Medical Center, Israel
Brief Summary

The prevalence of Abdominal Aortic Aneurysm among 65 years old individuals worldwide is 1-2%. when diagnosis is confirmed by abdominal Ultrasound the prevalence is 5.5% in men and 1% in women.

As abdominal aortic aneurysm and coronary heart disease share common risk factors, patients with acute coronary syndrome represent a high risk population in which screening for another atherosclerotic site is recommended.

Patients admitted for ACS undergo routinely TTE. during the same study, TTE may offer the opportunity to evaluate the cardiac morphology and function and to screen for Abdominal Aortic aneurysm. It was reported by different studies that the Sensitivity of this technique was between 91-96% for AAA screening.

In addition, this method is cheap, available and requires only 2-3 minutes to be added to the standard TTE.

we plan to examine patients admitted with ACS in our Intensive Care Unit for screening AAA by TTE in subcostal views in addition to the standard TTE examination.

Overall Status Completed
Start Date May 2013
Completion Date July 2015
Primary Completion Date July 2015
Study Type Observational
Primary Outcome
Measure Time Frame
Abdominal aortic diameter measurement of 30 mm or more by portable transthoracic echocardiography, will be defined as abdominal aortic aneurysm. Average time period of 72 hours.
Enrollment 90
Condition
Eligibility

Sampling Method: Probability Sample

Criteria:

Inclusion Criteria:

- patients over 65 years old with ACS. patients capable of reading, understanding and signing informed concent

Exclusion Criteria:

- suboptimal TTE windows

Gender: All

Minimum Age: 65 Years

Maximum Age: 100 Years

Healthy Volunteers: No

Overall Official
Last Name Role Affiliation
Mohamad Jabaren, MD Principal Investigator Haemek Medical Center, Afula, Israel
Location
Facility:
HaEmek MC Cardiology depratment | Afula, 18100, Israel
Haemek Medical Center | Afula, Israel
Location Countries

Israel

Verification Date

December 2016

Responsible Party

Type: Principal Investigator

Investigator Affiliation: HaEmek Medical Center, Israel

Investigator Full Name: Mohamed Jabaren

Investigator Title: MD

Keywords
Has Expanded Access No
Condition Browse
Patient Data No
Study Design Info

Time Perspective: Prospective

Source: ClinicalTrials.gov